Allison M.L. Nixon

926 total citations
6 papers, 316 citations indexed

About

Allison M.L. Nixon is a scholar working on Oncology, Molecular Biology and Nephrology. According to data from OpenAlex, Allison M.L. Nixon has authored 6 papers receiving a total of 316 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Oncology, 3 papers in Molecular Biology and 1 paper in Nephrology. Recurrent topics in Allison M.L. Nixon's work include Cancer Cells and Metastasis (3 papers), CAR-T cell therapy research (2 papers) and Ubiquitin and proteasome pathways (2 papers). Allison M.L. Nixon is often cited by papers focused on Cancer Cells and Metastasis (3 papers), CAR-T cell therapy research (2 papers) and Ubiquitin and proteasome pathways (2 papers). Allison M.L. Nixon collaborates with scholars based in Canada, United States and Hong Kong. Allison M.L. Nixon's co-authors include Jason Moffat, Anthony B. Mak, Jasna Ćurak, Anne‐Claude Gingras, Igor Štagljar, Ralph Mazitschek, Jocelyn M. Stewart, Saranya Kittanakom, Benjamin G. Neel and Ginny I. Chen and has published in prestigious journals such as PLoS ONE, Journal of Molecular Biology and Cancer Research.

In The Last Decade

Allison M.L. Nixon

6 papers receiving 312 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Allison M.L. Nixon Canada	6	204	161	43	38	32	6	316
Yi Hong China	13	217 1.1×	101 0.6×	42 1.0×	44 1.2×	32 1.0×	18	344
Hwajin Son South Korea	3	187 0.9×	116 0.7×	82 1.9×	37 1.0×	28 0.9×	4	290
Kristen Bisanz United States	6	287 1.4×	124 0.8×	58 1.3×	47 1.2×	37 1.2×	7	389
Luigi Alfano Italy	11	271 1.3×	95 0.6×	45 1.0×	45 1.2×	36 1.1×	23	396
Federica Lorenzi United Kingdom	6	230 1.1×	192 1.2×	104 2.4×	35 0.9×	24 0.8×	8	372
PengXin Zhang China	9	261 1.3×	97 0.6×	55 1.3×	39 1.0×	46 1.4×	31	386
Kirti Lohite India	5	187 0.9×	107 0.7×	103 2.4×	22 0.6×	43 1.3×	5	371
Yasuyuki Kaneta Japan	8	174 0.9×	75 0.5×	39 0.9×	22 0.6×	39 1.2×	10	290
Qionghua Zhu China	10	384 1.9×	128 0.8×	93 2.2×	31 0.8×	41 1.3×	13	474
Silvia Licciulli Italy	8	366 1.8×	127 0.8×	83 1.9×	59 1.6×	45 1.4×	8	470

Countries citing papers authored by Allison M.L. Nixon

Since Specialization

Citations

This map shows the geographic impact of Allison M.L. Nixon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Allison M.L. Nixon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Allison M.L. Nixon more than expected).

Fields of papers citing papers by Allison M.L. Nixon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Allison M.L. Nixon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Allison M.L. Nixon. The network helps show where Allison M.L. Nixon may publish in the future.

Co-authorship network of co-authors of Allison M.L. Nixon

This figure shows the co-authorship network connecting the top 25 collaborators of Allison M.L. Nixon. A scholar is included among the top collaborators of Allison M.L. Nixon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Allison M.L. Nixon. Allison M.L. Nixon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

1.

Nixon, Allison M.L., M. A. McLaughlin, Jennifer Haynes, et al.. (2019). A rapid in vitro methodology for simultaneous target discovery and antibody generation against functional cell subpopulations. Scientific Reports. 9(1). 842–842. 10 indexed citations

2.

Mak, Anthony B., Mariana Pehar, Allison M.L. Nixon, et al.. (2014). Post-Translational Regulation of CD133 by ATase1/ATase2-Mediated Lysine Acetylation. Journal of Molecular Biology. 426(11). 2175–2182. 34 indexed citations

3.

Mak, Anthony B., Allison M.L. Nixon, & Jason Moffat. (2012). The Mixed Lineage Leukemia (MLL) Fusion–Associated Gene AF4 Promotes CD133 Transcription. Cancer Research. 72(8). 1929–1934. 35 indexed citations

4.

Hallett, Robin, Maria Kondratyev, Andrew O. Giacomelli, et al.. (2012). Small Molecule Antagonists of the Wnt/Beta-Catenin Signaling Pathway Target Breast Tumor-Initiating Cells in a Her2/Neu Mouse Model of Breast Cancer. PLoS ONE. 7(3). e33976–e33976. 78 indexed citations

5.

Mak, Anthony B., Allison M.L. Nixon, Saranya Kittanakom, et al.. (2012). Regulation of CD133 by HDAC6 Promotes β-Catenin Signaling to Suppress Cancer Cell Differentiation. Cell Reports. 2(4). 951–963. 149 indexed citations

6.

Msaouel, Pavlos, et al.. (2005). Extracellular calcium sensing receptor: an overview of physiology, pathophysiology and clinical perspectives.. PubMed. 18(6). 739–53. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact